• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

  • Twitter
  • YouTube
NASBS

NASBS

North American Skull Base Society

  • Home
  • About
    • Mission Statement
    • Bylaws
    • NASBS Board of Directors
    • Committees
      • Committee Interest Form
    • NASBS Policy
    • Donate Now to the NASBS
    • Contact Us
  • Meetings
    • 2027 Annual Meeting
    • Abstracts
      • 2026 Call for Abstracts
      • NASBS Poster Archives
      • 2025 Abstract Awards
    • 2026 Recap
    • NASBS Summer Course
    • Meetings Archive
    • Other Skull Base Surgery Educational Events
  • Resources
    • Member Survey Application
    • NASBS Travel Scholarship Program
    • Research Grants
    • Fellowship Registry
    • The Rhoton Collection
    • Webinars
      • Research Committee Workshop Series
      • ARS/AHNS/NASBS Sinonasal Webinar
      • Surgeon’s Log
      • Advancing Scholarship Series
      • Trials During Turnover: Webinar Series
    • NASBS iCare Pathway Resources
    • Billing & Coding White Paper
  • Membership
    • Join NASBS
    • Membership Directory
    • Multidisciplinary Teams of Distinction
    • NASBS Mentorship Program
  • Fellowship Match
    • NASBS Neurosurgery Skull Base Fellowship Match Programs
    • NASBS Neurosurgery Skull Base Fellowship Match Application
  • Journal
  • Login/Logout

2026 Proffered Presentations

2026 Proffered Presentations

 

← Back to Previous Page

 

S001: THE USE OF CEREBRAL BYPASS IN THE SURGICAL MANAGEMENT OF SKULL BASE TUMORS: A SYSTEMATIC REVIEW OF THE LITERATURE
Emal Lesha; Delaney Graham; George Michael; Camille Milton; Aruha Khan; Nickalus Khan; University of Tennessee Health Science Center

Introduction: Tumors involving the skull base often require complex surgical management. The use of vascular bypass, whether extracranial to intracranial or intracranial to intracranial, has been previously described as a management option to ensure proper cerebral perfusion or to allow gross total resection. We aim to provide an up to date review of the utilization of bypass for skull base tumors, focusing on patient characteristics, management options, and treatment outcomes

Objective: To evaluate surgical outcomes, patency rates, and post-operative complications following bypass procedure for complex skull base tumors.

Methods: A systematic review was conducted using PRISMA guidelines. PubMed, Science Direct, and Scopus databases were searched from database inception until August 4, 2024.

Results: Among the 8,323 initially identified sources, 45 were included in the final review (Figure 1), for atotal of 376 patients with mean age 47.9 years. Meningioma (44.9%) was the most common pathology, followed by nasopharyngeal carcinoma (14.9%), squamous cell carcinoma (8.2%) and chondroma/chondrosarcoma (6.4%), as shown in Table 1. The most common reason for bypass was oncologic (94.6%) to allow gross total resection, followed by vascular (5.4%), including to allow adequate perfusion or due to intraoperative vascular injury. Gross total resection was achieved in 40.4% of reported cases. The most common type of bypass was ECA-ICA (46.6%), followed by ICA-ICA (43.2%) and CCA-ICA (8.7%), as shown in Table 2. The most common bypass related complications included graft stenosis (65.1%), post-operative stroke (25.6%) and bypass occlusion (9.3%). Bypass patency was 73.6% at latest follow up, with an average time to follow up of 18.9 months.

Conclusions: Cerebrovascular bypass is a treatment modality that can be used to maximize resection of complex skull base lesions while allowing for adequate cerebral perfusion.

 

← Back to Previous Page

Copyright © 2026 North American Skull Base Society · Managed by BSC Management, Inc · All Rights Reserved